Skip to Content
Top

BY Scott Merville

Patients with four types of cancer have new treatment options available after approval of three new drugs by the United States Food and Drug Administration in recent weeks.

The highly targeted drugs focus their firepower on specific types of cancer cells to treat groups of patients with non-small cell lung cancer, metastatic melanoma, Hodgkin lymphoma and anaplastic large cell lymphoma (ALCL). They offer new options for...

BY Scott Merville

An intravenously delivered genetic bomb primed to go off only in breast cancer cells kills tenacious breast cancer-initiating cells, MD...

BY Dana Lee

Day 2 of the Proton Therapy Center National Education Conference picks up where day 1 left off with insights into lung cancer, physics, dosimetry...

BY Dana Lee

The Proton Therapy Center National Education Conference is designed to educate healthcare professionals on the recent advances, current treatment modalities, and clinical trials in radiation oncology using proton therapy.

This post features key insights from most of the Day 1 speakers including information on proton therapy for multiple disease sites, and recent advances in the field.

Physics of Proton Therapy (Radhe Mohan...

BY Scott Merville

A blend of histone proteins and DNA that packs genes into chromosomes, chromatin influences gene expression, DNA repair and chromosome recombination...